StonvexLoading…
StonvexCore line items from FOSL's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2026 2026-01-03 | Annual 2024 2024-12-28 | Annual 2023 2023-12-30 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $1.00B | $1.14B | $1.41B | $1.68B |
Operating Income | $-19.08M | $-103.95M | $-143.02M | $-1.47M |
Net Income | $-77.84M | $-106.28M | $-156.66M | $-43.53M |
EPS (Diluted) | $-1.45 | $-1.94 | $-3.00 | $-0.85 |
Total Assets | $689.25M | $763.57M | $978.03M | $1.24B |
Total Liabilities | Not available | Not available | Not available | Not available |
Cash & Equivalents | $95.84M | $123.60M | $117.20M | $198.73M |
Free Cash Flow OCF − CapEx | $-60.46M | $39.93M | $-67.99M | $-124.12M |
Shares Outstanding | 58.35M | 53.25M | 52.49M | 51.84M |